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Obesity is a major public health crisis, with 1.6 billion adults worldwide being classified as
overweight or obese in 2014. Therefore, it is not surprising that the number of women who
are overweight or obese at the time of conception is increasing. Obesity during pregnancy is
associated with the development of gestational diabetes and preeclampsia. The developmental
origins of health and disease hypothesis proposes that perturbations during critical stages of
development can result in adverse fetal changes that leads to an increased risk of developing
diseases in adulthood. Of particular concern, children born to obese mothers are at a greater
risk of developing cardiometabolic disease. One subset of the population who are predisposed
to developing obesity are children born small for gestational age, which occurs in 10% of
pregnancies worldwide. Epidemiological studies report that these growth-restricted children
have an increased susceptibility to type 2 diabetes, obesity, and hypertension. Importantly
during pregnancy, growth-restricted females have a higher risk of developing cardiometabolic
disease, indicating that they may have an exacerbated phenotype if they are also overweight or
obese. Thus, the development of early pregnancy interventions targeted to obese mothers may
prevent their children from developing cardiometabolic disease in adulthood.
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1 Introduction
Obesity is clinically defined as having a BMI over 30 (World
Health Organization (WHO) 2015; http://www.who.int/
mediacentre/factsheets/fs311/en/), and is associated with
an increased risk of developing a number of comorbidi-
ties, including cardiovascular and metabolic diseases and
nephropathy [1]. A recent report byMcKinseyGlobal Institute
stated that obesity is considered one of the top three global so-
cial burdens generated by human beings, alongwith smoking
and armed violence, and it is estimated that $2.0 trillion USD
is spent worldwide annually as a result of obesity (McKinsey
Global Institute 2014; http://www.mckinsey.com/insights/
economic studies/how the world could better fight obesity).
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Since 1980, obesity rates worldwide have more than doubled
with 2.1 billion people, or nearly 30% of the global popula-
tion, classified as being obese or overweight in 2013 [2]. Of
major concern, there were 42 million children under 5 years
of age who are overweight or obese in 2013 according to the
WHO (2015).
The dramatic increase in the prevalence of obesity in
recent years is suggested to be caused by a poor early life
environment, which can have long-term effects on the sus-
ceptibility of the developing offspring to develop a wide range
of adverse conditions in adulthood. Indeed, there has been a
plethora of epidemiological and experimental evidence that
strongly suggest that alterations in the in utero environment,
due to maternal nutrition, including maternal obesity and
maternal undernutrition, programs the developing offspring
to develop cardiovascular and metabolic disease later in life
[3, 4]. The disturbances during critical stages of development
can result in adverse changes in fetal physiology, which pre-
dispose the fetus to a number of diseases in adulthood. In
fact, other studies relate insults during critical periods of
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development to adverse conditions later in life, such as type
2 diabetes [4, 5], hypertension [6, 7], and obesity [8, 9]. The
fetus often responds to the poor conditions in an adverse
intrauterine environment by undergoing physiological and
metabolic adaptations in order to protect the most vital or-
gans, such as brain, at the detriment of other organs [10].
This “thrifty phenotypes hypothesis” suggests that when the
postnatal nutritional environment is similar, the individuals
would then be able to endure the poor condition, but the adap-
tations become detrimental when the postnatal nutrition is
different than the in utero environment [10, 11].
2 Obesity in pregnancy
Pregnancy is the greatest physiological challenge facing
women that results in alterations in maternal physiology and
metabolism to assist in fetal growth and development, which
ismodulated by a number of keymolecules [12]. For example,
glucose, the primary nutrient crossing the placenta, is impor-
tant for fetal and placental growth [12,13]. During pregnancy,
glucose homeostasis in the mother is altered so that there is
a progressive increase in insulin resistance and gluconeoge-
netic activity to sustain glucose transfer to the fetus [14]. Lipid
metabolism is also altered in pregnancy with a significant in-
crease in plasma cholesterol and triglyceride concentrations
due to enhanced lipolytic activity and reduced lipoprotein li-
pase activity of adipose tissue during late gestation [15, 16].
During the first and second trimester, the mother is in an
anabolic state whereby an increase in lipogenesis activity and
adipose tissue lipoprotein lipase activity causes the mothers
fat depots to accumulate [12]. The mother then shifts into a
catabolic state during late pregnancy when fetal growth accel-
erates [17].
In an obesemother, the pregnancy adaptations differ from
what occurs in healthy pregnant women. For example, glu-
cose metabolism is significantly altered with an increase in
peripheral and hepatic insulin resistance during the first
trimester of pregnancy compared to normal weight pregnant
women [18]. Therefore, is not surprising that the incidence of
gestational diabetes is higher in overweight or obese pregnant
women with a two- to tenfold increase [19–23]. In fact, obese
women who were not diagnosed with gestational diabetes or
impaired glucose tolerance have higher glucose profiles than
normal weight women both during early and late pregnancy,
despite consuming a controlled diet [24]. Similarly, women
who had a higher gestational weight gain throughout the
first 24 wks of pregnancy have a greater risk of developing
gestational diabetes [25] and the risk was more pronounced
when the women were obese [26]. Clearly, there is a linear
association between BMI and the incidence of gestational di-
abetes. The mechanisms underlying this adverse pregnancy
outcome are poorly understood. However, abdominal fat ac-
cumulation in obese women during pregnancy is likely to be
associated with an increase in inflammatory cytokine produc-
tion, leading to insulin resistance [27].
Obesity is a chronic low-grade inflammatory condition
that is characterized by increased adipocytemass, an increase
in fasting whole body free fatty acids, and glycerol released
from adipocytes [28]. White adipose tissue produces several
proinflammatory cytokines, such as TNF- and IL-6, which
are increased in obesity [29]. Importantly, the placenta also
produces these inflammatory cytokines, with the exception
of adiponectin [30,31]. Similar to the upregulation of inflam-
matory cytokine expression in obese adipose tissue, there is
a two- to threefold increase in proinflammatory cytokine ex-
pression (IL-1, TNF-, and IL-6) in the obese placenta, which
is likely due to increased macrophage infiltration compared
to a healthy pregnant women [32]. Likewise, the plasma con-
centrations of C-reactive protein, IL-6, and leptin were also
increased in pregnant obese women compared to normal
weight women [27, 32]. Obese women who were diagnosed
with gestational diabetes were reported to have low serum
adiponectin, a marker for increased insulin sensitivity, at 24–
28 wk of pregnancy as compared to womenwith obesity alone
[33]. Thus, these studies demonstrate that maternal obesity is
associated with increased inflammatory mediator expression
in the maternal plasma and placenta, which may contribute
to an inflammatory in utero environment for the developing
fetus.
3 The effects of maternal obesity on
offspring health
It is well established that maternal obesity is associated with
increased fetal growth, which can lead to offspring being
born macrosomic [34]. However, recent findings suggest that
offspring born to obese mother can also be small for ges-
tational age or born with a normal birth weight [35, 36]. Of
particular note, being small or large for gestational age due
to maternal obesity predispose the offspring to obesity in
adulthood [9]. Several animal studies have investigated the
relationship between maternal obesity and the development
of obesity in the offspring [37–39]. In rats, exposure to ma-
ternal obesity during pregnancy and lactation increased the
risk of obesity later in life [37, 38]. The risk of obesity was
further exacerbated when the offspring consumed a high
fat diet postweaning [37, 40]. These clearly indicate that ma-
ternal obesity increased the obesity risk in their offspring.
There are a number of mechanisms that may explain the pro-
graming effects of maternal obesity on offspring obesity risk
including programing of appetite dysregulation and altered
adipogenesis.
A study reported that the offspring of mice that con-
sumed a high fat diet throughout pregnancy and lactation
were hyperphagic from 4 to 6 wk of age before they devel-
oped abdominal obesity at 3 months [39]. Similarly, offspring
of rats exposed to a junk food diet during both pregnancy
and lactation displayed an increased preference for fatty, sug-
ary, and salty foods when compared to offspring exposed
to a control diet [37]. Programed changes in the offspring
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of obese mothers may be a consequence of changes in hy-
pothalamic functioning, which has an important role in the
regulation of appetite. Appetite is primarily regulated by the
hypothalamic arcuate nucleus and is composed of two neu-
ron populations that either express the appetite stimula-
tor neuropeptide Y (NPY) or the appetite inhibitor pro-
opiomelanocortin (POMC) [41]. These neurons project into
the paraventricular nucleus where they exert their effect on
appetite regulation [41]. Importantly, the development of ap-
petite regulation occurs during late gestation and perturba-
tions during these critical periodsmay lead to a dysregulation
in the expression of hypothalamic neuropeptides, increasing
the risk of obesity in adulthood [41]. In rats, offspring of
dams exposed to a cafeteria diet during pregnancy and lac-
tation have increased hypothalamic NPY signaling [42]. Ad-
ditionally, offspring born from genetically obese Zucker rats
had reduced expression of POMC and lower -melanocyte
stimulating hormone, a cleaved product of POMC [43]. It is
suggested that the changes in these neuronal pathways may
be due to increased circulating leptin and insulin in the obese
state, which are known to play a major role in regulating ap-
petite by stimulating POMC and inhibiting NPY hypothala-
mic neurons [44,45]. Therefore, it is postulated that exposure
to maternal obesity causes alterations in hypothalamic regu-
lation of appetite in the offspring leading to the development
of hyperphagia.
Maternal obesity is also associated with dysfunction in
offspring adipose tissue development. Offspring of rat dams
fed a “junk food” diet during gestation and lactation demon-
strated adipocyte hypertrophy, independent of hyperplasia,
with increased expression of adipogenic factor peroxisome
proliferator-activated receptor gamma, insulin-like growth
factor 1, insulin receptor substrate 1, and vascular endothe-
lial growth factor AmRNA expression at 10 wk of age, indica-
tive of altered adipocyte proliferation [46]. Similarly, maternal
overnutrition during late gestation in sheep is also associated
with increased expression of genes, which regulate adipogen-
esis and lipogenesis in fetal perirenal adipose tissue, includ-
ing lipoprotein lipase, adiponectin, leptin, and peroxisome
proliferator-activated receptor gamma [47]. These findings
suggest that alterations in adipose gene expression may be
one of the underlying mechanisms that increase adiposity in
offspring that are exposed to maternal overnutrition.
In addition to increasing the risk of offspring obesity,
maternal obesity and overnutrition also program metabolic
dysfunction in their offspring. Limited human studies have
examined the link between maternal obesity, offspring in-
sulin resistance, and other adverse metabolic outcomes. For
instance, the Hyperglycemia and Adverse Pregnancy Out-
come (HAPO) study reported that an increase in maternal
BMI is linked with fetal hyperinsulinemia, which is inde-
pendent of maternal glycaemia [48]. Importantly, there is evi-
dence that demonstrates that babies of obesemothers develop
insulin resistance in utero, indicating that maternal obesity
is an important predictor of metabolic disease in their off-
spring [49]. The effect maternal obesity has on insulin sensi-
tivity then persists into later life with children of overweight
women having an increased risk of developing insulin re-
sistance by 11 years of age [4], and in early adulthood (early
20s) [50]. Therefore, these findings support the association of
maternal obesity and altered glucose–insulin homeostasis in
the offspring.
Indeed, in animal studies, maternal obesity or
overnutrition during both pregnancy and lactation is linked
to increased insulin and glucose concentrations in the off-
spring and these features were exacerbated when the off-
spring consumed a high-fat diet postweaning [39, 46, 51–53].
Studies suggest that alteration in glucose–insulin homeosta-
sis in offspring of obese mothers is likely due to -cell failure
[54–57]. Evidence in rat studies demonstrated consumption
a high-fat diet (40% calories from fat) during pregnancy and
lactation caused hyperglycemia and insulin resistance with
compromised -cell development and function in the off-
spring [54, 55]. Additionally, offspring of obese mice develop
insulin resistance at 3 months of age, but by 6 months of
age male offspring developed frank diabetes with reduced
plasma insulin and pancreatic insulin content, indicative of
-cell exhaustion [39]. Other animal studies recorded similar
observations, suggesting that there is an age-related decline
in -cell function in offspring of obese mothers that leads to
altered glucose and insulin homeostasis [56,57]. In sheep,ma-
ternal obesity is linked to an increased fetal pancreatic weight
and an increased number of insulin-positive cells per unit
area, which is indicative of accelerated -cell maturation [58].
A further study showed that offspring of high-fat dams had
reduced -cell numbers and this was associated with an in-
creased in -cell apoptotic rate [59]. Therefore, these changes
may predispose the offspring to a premature loss of -cell
function which would subsequently lead to elevated risk of
metabolic disease in adulthood.
Taken together, these findings suggest that maternal obe-
sity or overnutrition during pregnancy have an adverse effect
on offspring metabolic outcomes [60]. Thus, further studies
are required to understand the underlying mechanisms that
predispose the offspring of obese mother to metabolic dis-
eases and whether these adverse phenotypes can be modified
by lifestyle interventions.
4 Intrauterine growth restriction
Obesity is a multifactorial disease, with a number of risk
factors associated with its development. Exposure to a per-
turbations in utero, such as maternal malnutrition and pla-
cental insufficiency, program an increased risk of developing
obesity in later life [61]. Intrauterine growth restriction af-
fects 10% of pregnancies worldwide and is characterized by
a term birth weight of less than 2.5 kg [62]. Growth restric-
tion can be caused by genetic factors and maternal stressors,
such as maternal smoking, maternal malnutrition, and pla-
cental dysfunction [63]. In Western societies uteroplacental
insufficiency is the major cause of growth restriction [64–66],
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whereas maternal malnutrition is the main cause of babies
born small in developing countries [67,68]. Previous epidemi-
ological studies have demonstrated an association between
being born small and an increased risk of developing type
2 diabetes, obesity, and hypertension [5, 6, 69]. From these
findings the importance of maternal nutrition and its effect
on birth weight and subsequent adult diseases was addressed
in human studies of famine exposure, particularly the Dutch
Hunger Winter of 1944–1945 [70, 71]. The Dutch Hunger
Winter study found that growth restriction due to famine ex-
posure in utero is linked to glucose intolerance and abdom-
inal obesity in adults [70, 72]. In contrast, the findings from
famine exposure during the Leningrad siege (1941–1944) did
not show any association between birth weight andmetabolic
disease risk [73]. The inconsistency between these findings
is likely due to the different nutritional environments dur-
ing the postnatal period in both studies. Following the Dutch
HungerWinter, the food supply was restored to normal levels
in a short period of time, where they were exposed to normal
nutrition during their postnatal life [70, 73]. Conversely in
Leningrad, the children were exposed to poor nutritional en-
vironment in utero and in their early postnatal years [73].
These findings suggest that a mismatch in nutritional envi-
ronment between the intrauterine and postnatal period may
influence the outcomes of growth-restricted babies in adult-
hood.
Altered postnatal growth can also influence the disease
outcomes of growth-restricted babies in adulthood. Growth-
restricted babies often experience catch up growth in the first
6 to 12months of age and to as late as 2 years after birth when
the postnatal nutritional environment is improved [74]. They
will accelerate their growth trajectory to match the growth
of normal weight babies to compensate for their low birth
weight. Previous studies have reported that children born
small for gestational age, who have a high childhood fat
mass, have an increased risk of developing diabetes in later
life [75, 76] and present with insulin resistance at 3 years
[77]. Another study in a cohort from Helsinki demonstrated
that growth-restricted individuals have an exacerbated risk of
type 2 diabetes when catch up growth in early postnatal life
(6 months of age) is combined with accelerated weight gain
during adolescence [78]. These studies suggest that acceler-
ated catch up growth during postnatal life is an additional
independent risk factor to disease development in growth-
restricted individuals. Therefore, a combination of adverse
pre- and postnatal environment can lead to an exacerbation
of the programed diseases in these individuals.
Animal models have been extensively used to identify the
underlying mechanisms that associate intrauterine growth
restriction and the risk of metabolic dysfunction in adult-
hood. Indeed, many studies using a wide range of ani-
mal species, including sheep, rodents and guinea pig, have
demonstrated the link between intrauterine growth restric-
tion and metabolic disease [79]. The majority of animal
models investigating intrauterine growth restriction have
utilized dietary interventions to induce maternal undernu-
trition [80, 81] and surgical interventions to induce utero-
placental insufficiency [82]. In Wistar rat, exposure to 50%
caloric restriction in the last trimester of pregnancy resulted
in a 16% reduction in birth weight compared to control off-
spring [83, 84]. However, the effect caloric restriction has on
adiposity is contradictory with this study identifying no
change [83, 84], whereas another study identified increased
adiposity, which is consistent with the hyperleptinemia ob-
served in these animals [85]. Despite these differences in
adiposity, caloric restriction results in catch up growth [86]
and alters -cell morphology and function [83, 84]. Specifi-
cally, caloric restriction and low-protein diets (8% protein)
reduce -cell mass [83, 87–89] and insulin content [83, 87].
Interestingly, when these offspring were exposed to a nor-
mal diet postnatally, the islet morphology improved, indi-
cating that the in utero environment influences fetal islet
development [88, 89]. However, if protein restriction was ex-
tended duringweaning, thesemodifications were irreversible
[88,89]. Studies inmale rat offspring of low-protein diet dams
demonstrated an age-dependent loss in glucose tolerance.
Specifically, they had improved glucose tolerance and re-
duced plasma insulin concentrations in early life (6 wk to
3 months), which is indicative of enhanced insulin sensitiv-
ity [90]. Nevertheless, when they reached 15 months of age,
glucose intolerance was evident [91] and by 17 months of age
they developed frank diabetes and insulin resistance [92].
As mentioned previously in developed countries, placen-
tal insufficiency is the major cause of intrauterine growth
restriction and low birth weight [64–66]. Wigglesworth was
the first to describe the model of uteroplacental insufficiency
in rats by ligating the uterine vessels during late gestation,
which reduced uteroplacental nutrient and oxygen perfusion
and thus compromises fetal growth and development [82].
This rat model is equivalent to the degree of birth weight
reduction observed in humans in developed countries (10–
15% reduction in birth weight), where developmental insults
are most apparent during late gestation [93]. Uteroplacental
insufficiency surgery in Sprague Dawley rats between em-
bryonic days 16 and 19 (E16-19; term = 22 days) resulted in
low birth weight offspring (10–15%) [64, 94, 95]. These off-
spring had reductions in -cell mass at birth [95, 96], with
a similar decrease in pancreatic insulin content [95], how-
ever, glucose tolerance was normal at 3 months of age [95]. In
contrast, a study by Simmons et al. reported thatmale growth-
restricted Sprague Dawley rats had normal -cell mass, islet
size, and pancreatic weight at 1 and 7wk of age [64]. However,
at 15 wk of age, these rats had reduced -cell mass and de-
creased pancreatic insulin content aswell as a reduced insulin
response to glucose, and at 26 wk these offspring were dia-
betic and obese [64]. Additionally, other uteroplacental insuf-
ficiency studies recorded fasting hyperglycemia, early onset
insulin resistance, obesity, and impaired glucose tolerance in
the growth-restricted Sprague Dawley rats [64, 65, 97–100].
Findings from our laboratory reported that male Wistar
Kyoto (WKY) rats that were exposed to uteroplacental in-
sufficiency develop impaired glucose tolerance and were
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hyperinsulinemic at 6 month of age, which was associated
with a 40–45% reduction in -cell mass [101–104]. Interest-
ingly, growth-restricted female rats exhibited normal glucose
tolerance regardless of reductions in basal insulin concen-
trations and pancreatic -cell mass [101, 105]. Findings from
these studies clearly suggest that there are sex-specific dif-
ferences where growth-restricted males are more severely af-
fected than females. Thus, “second hits,” such as obesity or
pregnancy, may exacerbate the adverse metabolic phenotype
in growth-restricted females.
4.1 Growth restriction and obesity
Epidemiological studies and animal models link a low birth
weight to an increased risk of adult obesity and metabolic
syndrome [106, 107]. Early epidemiologic studies demon-
strated that growth-restricted babies that experienced accel-
erated catch up growth have a higher risk of obesity and
metabolic syndrome compared to infants that are born small
and remain small throughout their life [108, 109]. Impor-
tantly, growth-restricted infants with catch up growth during
their early postnatal life had reduced lean body mass and ele-
vated abdominal fat [110,111]. This finding is similar to what
is reported in infants with a normal birth weight that exhibit
rapid weight gain in the first 2 years of life [112]. Of partic-
ular concern, the Dutch Hunger Winter study reported that
only women who were exposed to famine in early gestation
had increased in body weight, BMI, and waist circumference
in adulthood [72]. Likewise, girls aged between 14 and 16
years who were born small had increased central adiposity
compared to growth-restricted males [113]. These findings
indicate that growth-restricted females are at higher risk of
abdominal obesity which is associated with an increased risk
of insulin resistance and glucose intolerance.
4.2 Growth restriction and pregnancy
In females that were born growth-restricted, pregnancy may
exacerbate their risk of cardiovascular and metabolic disease
due to an increase in both maternal and fetal demands. In-
deed, epidemiological studies associate a low birth weight
with a higher risk of developing preeclampsia during later
pregnancy [114, 115]. Furthermore, women born with a low
birth weight were also more susceptible to gestational dia-
betes during pregnancy compared to women that were born
of normal weight [116]. A study in female rats born small also
identified a higher risk of developing gestational diabetes in
pregnancy as well as an increased risk of their offspring devel-
oping an altered metabolic phenotype [94]. Likewise, we have
previously demonstrated that growth-restricted female rats
during late pregnancy develop glucose intolerance, despite a
normal plasma insulin response [105]. Given that maternal
obesity has adverse effects on glucose homeostasis during
pregnancy, it is likely that the metabolic dysfunction in preg-
nant females who were born growth-restricted will be exac-
erbated if they consume a high-fat diet. Currently this asso-
ciation has not been investigated, thus future studies should
examine this interaction.
So far, most of the developmental programing studies
are largely descriptive and there are very limited molecular
investigations have been performed in this area. Therefore,
additional molecular studies are required to identify the un-
derlying mechanisms that may explain the link of obesity
in growth-restricted mothers to their pregnancy outcomes as
well as their offspring development.
5 Potential intervention
There has been much interest in the development of
lifestyle interventions targeting overweight and obese preg-
nant women. Of particular interest, epidemiological studies
demonstrated that exercise in overweight and obese women
prevented them from developing gestational diabetes as well
as deliveringmacrosomic babies [117].Moderate exercise dur-
ing pregnancy improved glucose tolerance [118] and reduced
fasting insulin [119] in obese pregnant women; thus, low-
ering their risk for gestational diabetes. Likewise, moderate
to vigorous exercise in early pregnancy also improved in-
sulin response and sensitivity, as well as reducing plasma
triglyceride concentration in overweight and obese pregnant
women [120]. However, there are studies that failed to asso-
ciate the beneficial effects of exercise with a reduced risk of
adverse pregnancy outcomes in overweight and obesewomen
[121, 122]. Lack of consistent evidence regarding the bene-
fits of exercise in pregnant obese or overweight women sug-
gests that interventions during pregnancy alone may not be
enough to ameliorate the adverse effect obesity has on the
mother and her children. Therefore, an exercise interven-
tion before and during pregnancy may be more beneficial.
Indeed, in nonobese pregnant women who were involved
in exercise training 1 year before pregnancy had a reduced
risk of developing gestational diabetes [123–125], and the ef-
fect was greater in women who exercised before and during
pregnancy [125]. These findings propose that these lifestyle
interventions aremore beneficial if they are performed before
the reproductive years.
Similarly, in animal studies, maternal exercise reduced
the metabolic risk caused by maternal obesity in both the
mother and offspring [126, 127]. A recent study on rats re-
ported that voluntary wheel running before and during preg-
nancy prevented the increase in plasma insulin and glucose,
concentrations insulin resistance (HOMA-IR), and plasma
triglyceride content during lactation in obese dams [126]. Ad-
ditionally, voluntary exercise before and during pregnancy re-
duced glucose and insulin concentrations in male offspring
(postnatal day 19) of obese rat mothers [128] and prevented
glucose intolerance induced by maternal obesity in female
offspring (24 wk) of C57BL/6 mice [128]. Of particular con-
cern, most of the rodent studies investigating the effect of
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exercise intervention inmaternal obesity utilized a poorly con-
trolled voluntary wheel running as the exercise intervention.
Therefore, a well-controlled interventional animal study us-
ing a motorized treadmill exercise is required as precise ex-
ercise intensity and duration can be controlled.
6 Conclusions
There has been a significant increase in the number of over-
weight or obese pregnant women in the past two decades. Of
particular concern, maternal obesity does not only affect the
mother, but the offspring are programed to develop obesity
and metabolic disease later in life. Studies suggest that the
mechanisms contributing to this is due to appetite dysreg-
ulation and enhanced adipogenesis in the offspring. Being
born small for gestational age is one of the risk factor for
developing obesity. As being born small is associated with
increased risk of cardiovascular and metabolic disease dur-
ing pregnancy, it is suggested that obesity during pregnancy
may exacerbate the risk of these diseases. However, there are
limited studies investigating the effect of maternal obesity in
growth-restrictedmothers and the subsequent effects in their
offspring. Therefore, it is critical to identify the underlying
mechanisms that link obesity in growth-restricted mothers
to the development of metabolic diseases in their offspring.
This will be fundamental to future strategies for the preven-
tion and therapy of obesity.
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